Curis Lifesciences Limited (NSE:CURIS)

India · Delayed Price · Currency is INR

165.70

+14.35 (9.48%)

At close: Sep 7, 2026

Market Cap	1.34B
Revenue (ttm)	606.29M +155.3%
Net Income	69.16M +1,304.6%
EPS	10.26 +1,046.0%
Shares Out	8.08M
PE Ratio	16.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60,000
Open	151.35
Previous Close	151.35
Day's Range	151.35 - 169.80
52-Week Range	83.60 - 169.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 4, 2026

About Curis Lifesciences

Curis Lifesciences Limited operates as a pharmaceutical manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as tablets, capsules, external preparations, oral liquid, and sterile ophthalmic ointments in India. The company's business model operates through loan license manufacturing, through which, the company carry outs manufacturing under Loan License arrangement for domestic suppliers, where all raw materials and excipients are procured and delivered by the client; contract manufacturing, where the comp... [Read more]

Industry Commercial Physical and Biological Research

Founded 2010

Country India

Stock Exchange National Stock Exchange of India

Ticker Symbol CURIS

Full Company Profile

Financial Performance

In fiscal year 2026, Curis Lifesciences's revenue was 606.29 million, an increase of 22.16% compared to the previous year's 496.32 million. Earnings were 69.16 million, an increase of 13.29%.

Financial Statements